Reply to J. Wei et al.

Lin, Nancy U; Pegram, Mark; Sahebjam, Solmaz; Ibrahim, Nuhad; Fung, Anita; Cheng, Anna; Nicholas, Alan; Kirschbrown, Whitney; Kumthekar, Priya

Lin, Nancy U; Pegram, Mark; Sahebjam, Solmaz; Ibrahim, Nuhad; Fung, Anita; Cheng, Anna; Nicholas, Alan; Kirschbrown, Whitney; Kumthekar, Priya.

Afiliación

Lin NU; Nancy U. Lin, MD, Dana-Farber Cancer Institute, Boston, MA; Mark Pegram, MD, Stanford Comprehensive Cancer Institute, Palo Alto, CA; Solmaz Sahebjam, MD, Moffitt Cancer Center, University of South Florida, Tampa, FL; Nuhad Ibrahim, MD, MD Anderson Cancer Center, Houston, TX; Anita Fung, PharmD, Anna
Pegram M; Nancy U. Lin, MD, Dana-Farber Cancer Institute, Boston, MA; Mark Pegram, MD, Stanford Comprehensive Cancer Institute, Palo Alto, CA; Solmaz Sahebjam, MD, Moffitt Cancer Center, University of South Florida, Tampa, FL; Nuhad Ibrahim, MD, MD Anderson Cancer Center, Houston, TX; Anita Fung, PharmD, Anna
Sahebjam S; Nancy U. Lin, MD, Dana-Farber Cancer Institute, Boston, MA; Mark Pegram, MD, Stanford Comprehensive Cancer Institute, Palo Alto, CA; Solmaz Sahebjam, MD, Moffitt Cancer Center, University of South Florida, Tampa, FL; Nuhad Ibrahim, MD, MD Anderson Cancer Center, Houston, TX; Anita Fung, PharmD, Anna
Ibrahim N; Nancy U. Lin, MD, Dana-Farber Cancer Institute, Boston, MA; Mark Pegram, MD, Stanford Comprehensive Cancer Institute, Palo Alto, CA; Solmaz Sahebjam, MD, Moffitt Cancer Center, University of South Florida, Tampa, FL; Nuhad Ibrahim, MD, MD Anderson Cancer Center, Houston, TX; Anita Fung, PharmD, Anna
Fung A; Nancy U. Lin, MD, Dana-Farber Cancer Institute, Boston, MA; Mark Pegram, MD, Stanford Comprehensive Cancer Institute, Palo Alto, CA; Solmaz Sahebjam, MD, Moffitt Cancer Center, University of South Florida, Tampa, FL; Nuhad Ibrahim, MD, MD Anderson Cancer Center, Houston, TX; Anita Fung, PharmD, Anna
Cheng A; Nancy U. Lin, MD, Dana-Farber Cancer Institute, Boston, MA; Mark Pegram, MD, Stanford Comprehensive Cancer Institute, Palo Alto, CA; Solmaz Sahebjam, MD, Moffitt Cancer Center, University of South Florida, Tampa, FL; Nuhad Ibrahim, MD, MD Anderson Cancer Center, Houston, TX; Anita Fung, PharmD, Anna
Nicholas A; Nancy U. Lin, MD, Dana-Farber Cancer Institute, Boston, MA; Mark Pegram, MD, Stanford Comprehensive Cancer Institute, Palo Alto, CA; Solmaz Sahebjam, MD, Moffitt Cancer Center, University of South Florida, Tampa, FL; Nuhad Ibrahim, MD, MD Anderson Cancer Center, Houston, TX; Anita Fung, PharmD, Anna
Kirschbrown W; Nancy U. Lin, MD, Dana-Farber Cancer Institute, Boston, MA; Mark Pegram, MD, Stanford Comprehensive Cancer Institute, Palo Alto, CA; Solmaz Sahebjam, MD, Moffitt Cancer Center, University of South Florida, Tampa, FL; Nuhad Ibrahim, MD, MD Anderson Cancer Center, Houston, TX; Anita Fung, PharmD, Anna
Kumthekar P; Nancy U. Lin, MD, Dana-Farber Cancer Institute, Boston, MA; Mark Pegram, MD, Stanford Comprehensive Cancer Institute, Palo Alto, CA; Solmaz Sahebjam, MD, Moffitt Cancer Center, University of South Florida, Tampa, FL; Nuhad Ibrahim, MD, MD Anderson Cancer Center, Houston, TX; Anita Fung, PharmD, Anna

J Clin Oncol ; 39(36): 4127-4128, 2021 12 20.

Article en En | MEDLINE | ID: mdl-34637335

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Clin Oncol Año: 2021 Tipo del documento: Article